Hemodynamic Monitoring Systems Market Size & Share, by Type (Invasive, Non-Invasive), End User (Hospitals, Ambulatory Surgical Centers, Home Healthcare), Product, Application - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5640
  • Published Date: Apr 30, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Hemodynamic Monitoring Systems Market size is expected to reach USD 50 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of hemodynamic monitoring systems was over USD 35 billion. The primary reason for the hemodynamic monitoring systems expansion is the swift advancement of technology to diagnose cardiac issues across the world.

The field of cardiovascular healthcare is changing dramatically as a result of technological breakthroughs that have ushered in a new era of sophisticated and accurate monitoring systems.  For instance, over 6.5 billion individuals own smartphones globally, and there is a rapidly growing opportunity to provide patients with cardiac diseases with digital healthcare. Numerous randomized controlled trials have now shown that different noninvasive digital health technologies just like hemodynamic monitoring systems can affect patient behaviors in the primary and secondary prevention of coronary artery disease as well as the prevention and management of heart failure.

In addition, the hemodynamic monitoring systems landscape will encounter a significant surge during the forecast period on account of the quick modification in the surgical techniques globally. To illustrate, the field of healthcare is quickly adopting 3D printing technologies. In contrast to just three in 2010, more than 110 US hospitals had point-of-care 3D manufacturing facilities in 2020. Made-to-measure prosthetics, replacement joints, and dental implants are all being produced using this technology. There is also ongoing research on the use of 3D printers to create skin tissue, organs, and even pharmaceuticals. The upgradation of the latest technological devices therefore directly fuels the amelioration of the hemodynamic monitoring systems market share.

Hemodynamic Monitoring Systems Market
Get more information on this report: Request Free Sample PDF

Hemodynamic Monitoring Systems Sector: Growth Drivers and Challenges

Growth Drivers

  • Aging population and increasing cardiovascular diseases - People who are older and more experienced are more vulnerable to cardiovascular disease. In adults, age is a risk factor in and of itself for cardiovascular disease (CVD); however, other variables such as frailty, obesity, and diabetes exacerbate these risks. It is well recognized that these variables exacerbate and worsen cardiac risk factors linked to the onset of advanced age.

    Over two-thirds of individuals over 70 years old who have CVD also have concomitant noncardiovascular illnesses, according to recent research. Seventy percent of such individuals will develop CVD. A comprehensive nationwide study of Medicare enrollees 65 years of age or older revealed that CVD was commonly co-occurring with diabetes (37–47%), anemia (39–51%), and arthritis (41–46%). As hemodynamic monitoring systems directly help in monitoring cardiovascular conditions the demand for these devices is constantly in surge globally.
  • Demand for minimally invasive monitoring - Because of comorbidities and age, more and more patients need accurate intraoperative hemodynamic monitoring. Appropriate threshold settings are necessary to avoid unfavorable outcomes from intraoperative hypotension or hypoperfusion. Patient-to-patient variations in these settings are common. Flow monitoring is the norm for perioperative fluid management in goal-directed treatment strategies.

    To evaluate and treat a patient's cardiovascular function, minimally invasive hemodynamic monitoring (MIHM) devices measure and track a number of hemodynamic parameters, such as blood pressure, cardiac output, and oxygen saturation. The incorporation of wireless and remote monitoring features into MIHM devices, enabling the transfer of data in real-time and remote patient information access is further propelling the hemodynamic monitoring systems market to touch the projected gains.
  • Integration of artificial intelligence (AI) in monitoring systems - Through the analysis of enormous volumes of patient data gathered from wearables, sensors, and patient-reported information, AI algorithms are essential to early detection. Vital indicators including blood pressure, heart rate, breathing rate, and others are included in this data.

    After processing this data, AI models create unique baselines for every patient, taking into consideration their age, gender, medical history, and current state of health. With the unification of AI with hemodynamic monitoring systems these devices provide more accurate data that help in treatment. This further helps the market to multiply its gains.


  • Massive cost of hemodynamic monitoring systems - One of the main causes of the current biodiversity issue is biological invasions. The magnitude of invasions' economic effects is often overlooked. There are many unanswered questions about the economic costs incurred by invading alien species (IAS), especially for developing nations, which have the fastest-growing economy in the world. Because these technologies are expensive and require a skilled workforce to run, some healthcare facilities may find it challenging to implement them. As a result, the hemodynamic monitioring devices market is estimated to have slow growth.
  • Hemodynamic monitoring can lead to many problems, such as deep vein thrombosis, lung infarction, infection, catheter knotting, balloon rupture, and dysrhythmias. The market is hampered by additional consequences such as arterial lines, thrombosis, and occlusion.
  • Invasive vs. Non-invasive Dilemma

Hemodynamic Monitoring Systems Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

USD 35 Billion

Forecast Year Market Size (2036)

USD 50 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Hemodynamic Monitoring Systems Segmentation

Type (Invasive, Non-Invasive)

The invasive segment in the hemodynamic monitoring systems market is estimated to gain the largest revenue share of 60% in the year 2036. The escalating global burden of cardiovascular diseases necessitates advanced monitoring techniques for accurate diagnosis and timely interventions and this will help to augment this segment in the market revenue. According to a recent World Heart Federation (WHF) report, the number of deaths from cardiovascular disease (CVD) increased from 12.1 million in 1990 to 20.5 million in 2021 on a global scale. Invasive hemodynamic monitoring systems, capable of providing detailed cardiovascular parameters, are crucial in managing complex cardiovascular conditions, such as heart failure and sepsis.

According to the World Health Organization (WHO), cardiovascular diseases account for approximately 31% of global deaths. The rising incidence of these conditions underscores the critical need for advanced monitoring tools like invasive hemodynamic devices to enhance patient care and outcomes. The demographic shift towards an aging population is associated with an increased prevalence of cardiovascular diseases. Elderly individuals often present with multiple comorbidities, making invasive monitoring essential for precise and individualized care.

End Users (Hospitals, Ambulatory Surgical Centers, Home Healthcare)

The hospital segment in the hemodynamic monitoring systems market is expected to garner the highest share of 40% in the year 2036 because of the prevalence of hospitals globally. According to the most recent estimate, 6% of acute care hospitals in Europe have an average daily prevalence of healthcare-associated infections (HAIs), impacting around 3.2 million patients annually. The global increase in the prevalence of cardiovascular diseases, coupled with other critical conditions, necessitates advanced monitoring tools within hospital settings.

Hemodynamic monitoring systems are vital for assessing and managing complex cases, contributing to improved patient outcomes. The growing number of surgical procedures, including cardiac surgeries, vascular interventions, and other complex surgeries, necessitates comprehensive monitoring solutions within hospitals. Hemodynamic monitoring systems play a crucial role in ensuring the stability and safety of patients undergoing various surgical interventions. Considering all these elements, the market in this segment will expand.

Our in-depth analysis of the global market includes the following segments:


  • Invasive
  • Non-Invasive

     End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Healthcare


  • Monitors
  • Disposables


  • Laboratory-based Monitoring Systems
  • Home-based Monitoring Systems
  • Hospital-based Monitoring Systems

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Hemodynamic Monitoring Systems Industry - Regional Synopsis

APAC Market Statistics

The hemodynamic monitoring systems market share in the Asia Pacific region is expected to hold the largest revenue share of 38% by the end of 2036. This expansion will be propelled by the increasing healthcare industry in countries like Japan, China, and the rest of the APAC region. 1.36 billion individuals in China have full-coverage basic medical insurance by the end of 2020, with coverage exceeding 95%.

Further, in Japan, a variety of sectors, including diagnostics, nursing, medical care, and preventative health, are testing and introducing the use of AI. Emerging growth areas include dementia care, medication discovery, genetic medicine, and imaging diagnosis, treatment, and surgical assistance. The Japanese medical industry is expected to have a 15 billion yen (9 billion USD) market size in 2025. The increasing focus on inventing the latest and most effective hemodynamic monitoring systems in the APAC region is propelling the market expansion.

North American Market Analysis

The hemodynamic monitoring systems market demand in the North American region is projected to hold the second-largest share during the forecast period. This huge expansion will be noticed due to the quick advancement of the development of wearable Minimally Invasive Hemodynamic Monitoring (MIHM) devices in this region. These movable gadgets provide patients with convenience by enabling them to carry out their regular activities under constant observation.

These gadgets also eliminate the need for intrusive procedures, which lowers the possibility of infections and consequences. New noninvasive and minimally invasive cardiac output monitoring techniques can be used to track hemodynamic trends and are based on a variety of physiological principles. This high demand for wearable minimally invasive hemodynamic monitoring will propel the hemodynamic monitoring systems market revenue.

Research Nester
Hemodynamic Monitoring Systems Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Hemodynamic Monitoring Systems Landscape

    • Edwards Lifesciences Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Medtronic plc
    • Baxter International Inc.
    • LiDCO Group plc
    • Deltex Medical Group plc
    • Pulsion Medical Systems SE
    • Cheetah Medical
    • Nihon Kohden Corporation
    • GE Healthcare
    • Philips Healthcare

In the News

  • Medtronic acquired INPEN, a leader in disposable insulin pens, for USD 1 billion in August 2023. This move expands Medtronic's diabetes management portfolio beyond pumps and continuous glucose monitoring systems.
  • Medtronic partnered with Verily Life Sciences to leverage AI and data analytics for designing and conducting more efficient clinical trials in September 2023. This aims to accelerate bringing new medical technologies to patients.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5640
  • Published Date: Apr 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The swift advancement of technology to diagnose cardiac issues across the world will majorly drive the market growth of the hemodynamic monitoring systems market.

The market size of the hemodynamic monitoring systems market is expected to get a CAGR of approximately 8% over the forecast period, i.e., 2024-2036.

The major players in the market are Edwards Lifesciences Corporation, Medtronic plc, Baxter International Inc., LiDCO Group plc, Deltex Medical Group plc., Pulsion Medical Systems SE, Cheetah Medical, Nihon Kohden Corporation, GE Healthcare, Philips Healthcare, Nihon Kohden Corporation, Terumo Corporation, Fukuda Denshi Co., Ltd., Sysmex Corporation, OMRON Corporation.

The invasive segment is anticipated to reap the largest market size with almost 60% by the end of 2036 and demonstrate substantial growth scopes.

The market in the APAC region is expected to have the largest market share by the end of 2036 and provide more business opportunities in the future.
Hemodynamic Monitoring Systems Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying